Mitoinhibitory effects of the tumor promoter 2-acetylaminofluorene in rat liver:: loss of E2F-1 and E2F-3 expression and cdk 2 kinase activity in late G1
Mitoinhibitory effects of the tumor promoter 2-acetylaminofluorene in rat liver:: loss of E2F-1 and E2F-3 expression and cdk 2 kinase activity in late G1
复制标题
DOI:
10.1016/j.jhep.2004.02.028
复制
发表时间:
2004-06-01
影响因子:
25.7
通讯作者:
Porsch-Hällström, I
中科院分区:
文献类型:
--
作者:
Ohlson, LCE;Koroxenidou, L;Porsch-Hällström, I
Background/Aims: Examine the mitoinhibitory effect of the liver tumor promoter 2-acetylaminofluorene (2-AAF) in vivo, with focus on the proteins regulating G1- and S progression.Methods: cdk 2 kinase assay to examine histone H1 phosphorylation. cdk 4 kinase assay to examine whether active cdk 4/cyclin D complexes, capable of phosphorylating Rb, are formed. Western blot to monitor protein expression.Results: cdk 4 kinase-mediated Rb phosphorylation was increased by AAF treatment. Nuclear expression of the transcription factors E2F-1 and E2F-3 was downregulated, while E2F-4 was decreased. 2-AAF treatment also markedly reduced cdk 2 kinase activity/histone H1 phosphorylation during G1/S-transition. Western blot showed loss of nuclear as well as cytoplasmic cyclin A and cyclin B protein after 2-AAF treatment, while the Rb protein level was markedly increased during G1. The cell cycle dependent elevation of nuclear p107 protein, seen in control livers, was not observed in AAF-treated animals.Conclusions: Effects of 2-AAF; Very low cdk 2 kinase activity that could possibly block G1/S-transition; increased pRb level together with diminished levels of transcription factors E2F-1 and -3, that could be responsible for reducing the expression of E2F target genes such as cyclin A and E2F-1. (C) 2004 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.